Drugs & TargetsFree FDA approves Opdivo and Yervoy for front-line advanced RCC April 20, 2018Vol.44 No.16
Drugs & TargetsFree FDA issues guidance on investigational in vitro diagnostics in oncology trials April 20, 2018Vol.44 No.16
Free Piantadosi leaves Cedars-Sinai for Alliance and Harvard April 20, 2018Vol.44 No.16By Paul Goldberg
Clinical RoundupFree Keytruda combination improved OS regardless of PD-L1 expression, including patients who tested negative for PD-L1 April 20, 2018Vol.44 No.16
Clinical RoundupFree Keytruda reduced risk of recurrence or death by over 40% vs. placebo as adjuvant therapy in resected, high-risk stage III melanoma April 20, 2018Vol.44 No.16
Clinical RoundupFree SU2C researchers find treatment strategy for stage I-III NSCLC April 20, 2018Vol.44 No.16
FreeIn Brief St. Baldrick’s commits $8 million to SU2C Pediatric Cancer Dream Team April 20, 2018Vol.44 No.16
FreeIn Brief Isabella Santos Foundation gives $5 million for rare & solid tumor program at Levine Children’s Hospital April 20, 2018Vol.44 No.16
